Boston Scientific Corp (BSX) - Medical Equipment - Deals and Alliances Profile

Boston Scientific Corp (BSX) - Medical Equipment - Deals and Alliances Profile


  • Products Id :- GDME519D
  • |
  • Pages: 192
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Boston Scientific Corp (Boston Scientific) is a medical device company that develops, manufactures and markets devices used in a range of interventional medical procedures. The company offers products in seven business groups, namely, Interventional Cardiology, Cardiac Rhythm Management (CRM), Peripheral Interventions, Electrophysiology, Endoscopy, Urology, Pelvic Health and Neuromodulation. The company markets its products to hospitals, clinics, outpatient facilities and medical offices worldwide. It has several manufacturing, distribution and technology centers worldwide. The company markets its products through direct sales organizations and a network of distributors and dealers in Europe, the Middle East, Africa, Asia-Pacific and the Americas. Boston Scientific is headquartered in Marlborough, Massachusetts, the US.

Boston Scientific Corp (BSX)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 7

List of Figures 9

Boston Scientific Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 10

Boston Scientific Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 11

Boston Scientific Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 12

Boston Scientific Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 13

Boston Scientific Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 14

Boston Scientific Corp, Medical Equipment, Deal Details 22

Asset Purchase 22

Boston Scientific Acquires Tissue Processing Technology and Facility from Neovasc for USD68 Million 22

Boston Scientific Acquires Resectr Tissue Resection Device from Distal Access 23

Boston Scientific Acquires LumenR Tissue Retractor System from LumenR 24

Boston Scientific Acquires Interventional Radiology Business Of CeloNova Biosciences 25

Boston Scientific Acquires Men's Health and Prostate Health Businesses from American Medical Systems for USD1.65 Billion 26

Boston Scientific Acquires Vascular Catheter Business of Bayer for USD414 Million 28

Boston Scientific Acquires fiXate Tissue Band From Anulex Technologies 29

Venture Financing 30

RenovoRx Raises USD7 Million in First Tranche of Venture Financing 30

Claret Medical Raises USD14.5 Million in Series C Financing 31

SetPoint Medical Raises USD30 Million in Series D Financing 32

Channel Medsystems Raises USD14.1 Million in Series C-1 Financing 34

Neuros Medical Raises USD20 Million in Series AA Financing 35

Amphora Medical Raises USD35.5 Million in Series B Financing 36

NxThera Raises Additional USD6 Million in Venture Financing 38

Claret Medical Raises USD11.2 Million Venture Financing 39

NeuroTronik Raises USD23 Million in Series B Financing 40

SetPoint Medical Raises Funds through Venture Financing 41

NxThera Raises Additional USD2.4 Million in Venture Financing 43

NxThera Raises USD12.2 Million in Venture Financing 44

Apama Medical Raises USD13 Million in Series C Financing 45

Securus Medical Raises USD10 Million in Series C Financing 46

nVision Medical Raises USD12 Million in Series B Financing 47

Apama Medical Raises USD9 Million in Venture Financing 48

nVision Medical Raises USD6.5 Million in Venture Financing 49

NxThera Raises USD40 Million Financing 50

TVA Medical Raises USD15 Million in Series C Financing 51

Setpoint Medical Raises Additional USD15 Million in Series C Venture Financing 52

Channel Medsystems Raises USD22 Million in Series C Financing Round 54

InterVene Raises USD5.9 Million in Series A Financing 55

EndoChoice Raises USD57 Million in Venture Financing 56

Apama Medical Raises USD11 Million in First Tranche of Series B Venture Financing Round 57

Claret Medical Raises up to USD18 Million in Series B Venture Financing 58

NxThera Raises Funds Through Extended Series C Financing 59

Amaranth Medical Raises Funds Through Venture Financing 60

Xlumena Raises USD 25 Million In Series C Financing Round 61

Sensible Medical Raises USD 20 Million In Venture Financing 62

Securus Medical Raises USD 6.5 Million In Series B Financing 63

Xlumena Raises USD 6 Million In Venture Financing 64

Apama Medical Raises USD 3.2 Million In Series A-1 Financing Round 65

NXThera Raises USD 18 Million In Series C Financing 66

Setpoint Medical Raises USD 27 Million In Venture Financing 67

Claret Medical Raises USD 3.6 Million In Venture Financing 68

Channel Medsystems Raises USD 9.7 Million In Series B Financing 69

Baronova Raises USD 27.3 Million In Series C Financing 70

EndoChoice Raises USD 43 Million In Venture Financing 72

Xlumena Raises USD 6 Million In Venture Financing 73

Securus Medical Group Secures USD0.25 Million in Venture Funding 74

Neuros Medical Raises USD 3.5 Million In Second Round Of Financing 75

Partnerships 76

Symetis Enters Into Licensing Agreement With Endoluminal Sciences For Transcatheter Aortic Valve Implantation 76

BridgePoint Medical Enters Into Licensing Agreement With Covidien 77

Veniti Enters into Distribution Agreement with Boston Scientific 78

Boston Scientific Partners with Mayo Clinic 79

Boston Scientific Enters into Sales Cooperation Agreement with Preventice 80

Boston Scientific Enters into Agreement with Brainlab 81

Boston Scientific Enters into Distribution Agreement with C. R. Bard for Lutonix DCB 82

Boston Scientific Enters into Co-Development Agreement with Asahi Intecc 83

Boston Scientific Enters Into Distribution Agreement With Fukuda Denshi For Neuromodulation Devices 84

Boston Scientific Enters Into Agreement With Philips Healthcare 85

Vodafone Group Enters Into Co-Development Agreement With Boston Scientific For Health Monitoring System 86

Boston Scientific Extends Co-Marketing Agreement With Lumenis For Holmium Laser Fibers 87

Merger 88

EndoChoice And Peer Medical To Merge 88

Novartis Enters into Licensing Agreement with Boston Scientific for Everolimus 89

Equity Offering 90

Symetis Withdraws French Public Offering of Shares 90

Corindus Vascular Robotics Raises USD45 Million in Private Placement of Shares 91

VENITI Raises USD25 Million in Series D Equity Financing 93

MValve Technologies Raises Additional Funds through Private Placement of Shares 94

Symetis to Raise USD109.1 Million in IPO 95

Preventice Raises Funds through Private Placement of Shares 96

EndoChoice Raises USD106 Million in IPO 97

Iowa Approach Raises Funds through Private Placement of Shares 99

Debt Offering 100

Boston Scientific Raises USD1 Billion in Public Offering of 4% Notes Due 2028 100

Boston Scientific Raises USD600 Million in Public Offering of 2.850% Notes Due 2020 102

Boston Scientific Raises USD750 Million in Public Offering of 3.850% Notes Due 2025 104

Boston Scientific Raises USD500 Million in Public Offering of 3.375% Notes Due 2022 106

Boston Scientific Completes Public Offering Of Notes Due 2018 For USD 600 Million 108

Boston Scientific Completes Public Offering Of Notes Due 2023 For USD 450 Million 110

Asset Transactions 112

Boston Scientific Acquires Men's Health and Prostate Health Businesses from American Medical Systems for USD1.65 Billion 112

Medifocus Completes Acquisition Of Prolieve Business From Boston Scientific For Up To USD5 Million 114

Acquisition 115

Boston Scientific to Acquire Augmenix for USD600 Million 115

Boston Scientific to Acquire VENITI 116

Boston Scientific Acquires Claret Medical for up to USD270 Million 117

Boston Scientific to Acquire Remaining 65% Stake in Cryterion Medical 118

Boston Scientific Acquires NxThera 119

Boston Scientific Acquires nVision Medical 120

Boston Scientific Acquires Securus Medical 121

Boston Scientific Acquires EMcision 122

Boston Scientific Announces Investment and Acquisition Option Agreement with Millipede 123

Boston Scientific Acquires Apama Medical 124

Boston Scientific Acquires Symetis for USD435 Million 125

Boston Scientific Acquires 15% Stake in Neovasc for USD7 Million 126

Boston Scientific Acquires EndoChoice for USD214 Million in Tender Offer 127

Boston Scientific Acquires Cosman Medical 129

Boston Scientific Acquires 25% Stake in Frankenman Medical 130

Boston Scientific Acquires Xlumena for USD76 Million 131

Boston Scientific Enters into Option Agreement to Acquire MValve Technologies 132

Boston Scientific Acquires Remaining 72% Stake in IoGyn 133

Vanguard Acquires 6.7% Stake In Boston Scientific 134

Boston Scientific Completes Acquisition of Bard Electrophysiology From C. R. Bard For USD 275 Million 135

Fidelity Acquires 10.5% Stake In Boston Scientific, Medical Device Company 137

EndoChoice Acquires RMS Endoskopie, Endoscopy Device Maker 138

Boston Scientific Completes Acquisition Of Vessix Vascular, Developer Of Catheter-Based Renal Denervation System, For Up to USD425 Million 139

Boston Scientific Completes Acquisition Of BridgePoint Medical, Cardiovascular Device Maker 141

Boston Scientific Completes Acquisition Of Rhythmia Medical, Cardiac Arrhythmia Device Maker, For Up To USD 265 Million 142

Boston Scientific Completes Acquisition Of Cameron Health For Up To USD 1.3 Billion 143

Covidien Completes Acquisition Of superDimension, Pulmonary Device Maker, For USD 300 Million 145

Boston Scientific Corp - Key Competitors 147

Boston Scientific Corp - Key Employees 148

Boston Scientific Corp - Locations And Subsidiaries 150

Head Office 150

Other Locations & Subsidiaries 150

Recent Developments 155

Financial Announcements 155

Jul 25, 2018: Boston Scientific announces results for second quarter 2018 155

Apr 25, 2018: Boston Scientific Reports Financial Results For First Quarter 2018 156

Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017 158

Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017 160

Oct 26, 2017: Boston Scientific Announces Results For Third Quarter 2017 161

Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 163

Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 165

Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 166

Corporate Communications 168

Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary 168

Legal and Regulatory 169

Jul 30, 2018: Nevro Announces Update on Patent Litigation 169

Jul 25, 2018: Nevro Announces Patent Litigation Update 170

Mar 28, 2018: Boston Scientific Prevails in U.K. Edwards Lifesciences Litigation 171

Government and Public Interest 172

Dec 22, 2017: Boston Scientific pacemakers and defibrillators 172

Nov 28, 2017: Boston Scientific Announces Update on LOTUS Edge Aortic Valve System 174

Mar 16, 2017: NICE Recommends Boston Scientific CRT-D Devices Powered By EnduraLife Battery Technology For Treatment Of Heart Failure 175

Mar 03, 2017: Boston Scientific Announces Six Finalists in 2nd Annual Connected Patient Challenge, Focused on Healthcare Data Analytics 176

Product News 177

May 16, 2018: Boston Scientific Announces Schedule of Presentations at EuroPCR 2018 177

Apr 16, 2018: Boston Scientific Prevails In European Patent Dispute With Edwards Lifesciences 178

Mar 23, 2018: Edwards Prevails In U.S. Patent Office Review That Finds Boston Scientific Transcatheter Valve Patent Claims Invalid 179

Jan 08, 2018: Spinal Cord Stimulation changes life of patient 180

Sep 13, 2017: New Unpublished Vascular Clinical Trial Results on drug-coated balloons Presented at VIVA 17 181

May 10, 2017: Boston Scientific to Present The LOTUS Valve System at EuroPCR 2017 182

May 09, 2017: Boston Scientific Receives U.S. FDA Approval For Resonate Family Of High-Voltage Devices 183

May 03, 2017: Boston Scientific Announces Scheduled Presentations at Heart Rhythm Society 2017 184

Feb 06, 2017: Boston scientific launches Resonate family of CRT-D devices in Europe 186

Other Significant Developments 187

Oct 01, 2018: Boston Scientific competition seeks innovative digital health concepts 187

Jun 21, 2018: SwedishAmerican First in Rockford to Offer ICD with Diagnostic Tool to Predict Heart Failure 188

Jan 29, 2018: Five devices for pediatrics get help in advancing to market 189

Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 190

Appendix 192

Methodology 192

About GlobalData 192

Contact Us 192

Disclaimer 192

List of Figures

Boston Scientific Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Boston Scientific Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Boston Scientific Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Boston Scientific Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Boston Scientific Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 10

Boston Scientific Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 11

Boston Scientific Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 12

Boston Scientific Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 13

List of Tables

Boston Scientific Corp, Medical Equipment, Key Facts, 2017 2

Boston Scientific Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Boston Scientific Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 10

Boston Scientific Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 11

Boston Scientific Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 12

Boston Scientific Corp, Deals By Market, 2012 to YTD 2018 13

Boston Scientific Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 14

Boston Scientific Acquires Tissue Processing Technology and Facility from Neovasc for USD68 Million 22

Boston Scientific Acquires Resectr Tissue Resection Device from Distal Access 23

Boston Scientific Acquires LumenR Tissue Retractor System from LumenR 24

Boston Scientific Acquires Interventional Radiology Business Of CeloNova Biosciences 25

Boston Scientific Acquires Men's Health and Prostate Health Businesses from American Medical Systems for USD1.65 Billion 26

Boston Scientific Acquires Vascular Catheter Business of Bayer for USD414 Million 28

Boston Scientific Acquires fiXate Tissue Band From Anulex Technologies 29

RenovoRx Raises USD7 Million in First Tranche of Venture Financing 30

Claret Medical Raises USD14.5 Million in Series C Financing 31

SetPoint Medical Raises USD30 Million in Series D Financing 32

Channel Medsystems Raises USD14.1 Million in Series C-1 Financing 34

Neuros Medical Raises USD20 Million in Series AA Financing 35

Amphora Medical Raises USD35.5 Million in Series B Financing 36

NxThera Raises Additional USD6 Million in Venture Financing 38

Claret Medical Raises USD11.2 Million Venture Financing 39

NeuroTronik Raises USD23 Million in Series B Financing 40

SetPoint Medical Raises Funds through Venture Financing 41

NxThera Raises Additional USD2.4 Million in Venture Financing 43

NxThera Raises USD12.2 Million in Venture Financing 44

Apama Medical Raises USD13 Million in Series C Financing 45

Securus Medical Raises USD10 Million in Series C Financing 46

nVision Medical Raises USD12 Million in Series B Financing 47

Apama Medical Raises USD9 Million in Venture Financing 48

nVision Medical Raises USD6.5 Million in Venture Financing 49

NxThera Raises USD40 Million Financing 50

TVA Medical Raises USD15 Million in Series C Financing 51

Setpoint Medical Raises Additional USD15 Million in Series C Venture Financing 52

Channel Medsystems Raises USD22 Million in Series C Financing Round 54

InterVene Raises USD5.9 Million in Series A Financing 55

EndoChoice Raises USD57 Million in Venture Financing 56

Apama Medical Raises USD11 Million in First Tranche of Series B Venture Financing Round 57

Claret Medical Raises up to USD18 Million in Series B Venture Financing 58

NxThera Raises Funds Through Extended Series C Financing 59

Amaranth Medical Raises Funds Through Venture Financing 60

Xlumena Raises USD 25 Million In Series C Financing Round 61

Sensible Medical Raises USD 20 Million In Venture Financing 62

Securus Medical Raises USD 6.5 Million In Series B Financing 63

Xlumena Raises USD 6 Million In Venture Financing 64

Apama Medical Raises USD 3.2 Million In Series A-1 Financing Round 65

NXThera Raises USD 18 Million In Series C Financing 66

Setpoint Medical Raises USD 27 Million In Venture Financing 67

Claret Medical Raises USD 3.6 Million In Venture Financing 68

Channel Medsystems Raises USD 9.7 Million In Series B Financing 69

Baronova Raises USD 27.3 Million In Series C Financing 70

EndoChoice Raises USD 43 Million In Venture Financing 72

Xlumena Raises USD 6 Million In Venture Financing 73

Securus Medical Group Secures USD0.25 Million in Venture Funding 74

Neuros Medical Raises USD 3.5 Million In Second Round Of Financing 75

Symetis Enters Into Licensing Agreement With Endoluminal Sciences For Transcatheter Aortic Valve Implantation 76

BridgePoint Medical Enters Into Licensing Agreement With Covidien 77

Veniti Enters into Distribution Agreement with Boston Scientific 78

Boston Scientific Partners with Mayo Clinic 79

Boston Scientific Enters into Sales Cooperation Agreement with Preventice 80

Boston Scientific Enters into Agreement with Brainlab 81

Boston Scientific Enters into Distribution Agreement with C. R. Bard for Lutonix DCB 82

Boston Scientific Enters into Co-Development Agreement with Asahi Intecc 83

Boston Scientific Enters Into Distribution Agreement With Fukuda Denshi For Neuromodulation Devices 84

Boston Scientific Enters Into Agreement With Philips Healthcare 85

Vodafone Group Enters Into Co-Development Agreement With Boston Scientific For Health Monitoring System 86

Boston Scientific Extends Co-Marketing Agreement With Lumenis For Holmium Laser Fibers 87

EndoChoice And Peer Medical To Merge 88

Novartis Enters into Licensing Agreement with Boston Scientific for Everolimus 89

Symetis Withdraws French Public Offering of Shares 90

Corindus Vascular Robotics Raises USD45 Million in Private Placement of Shares 91

VENITI Raises USD25 Million in Series D Equity Financing 93

MValve Technologies Raises Additional Funds through Private Placement of Shares 94

Symetis to Raise USD109.1 Million in IPO 95

Preventice Raises Funds through Private Placement of Shares 96

EndoChoice Raises USD106 Million in IPO 97

Iowa Approach Raises Funds through Private Placement of Shares 99

Boston Scientific Raises USD1 Billion in Public Offering of 4% Notes Due 2028 100

Boston Scientific Raises USD600 Million in Public Offering of 2.850% Notes Due 2020 102

Boston Scientific Raises USD750 Million in Public Offering of 3.850% Notes Due 2025 104

Boston Scientific Raises USD500 Million in Public Offering of 3.375% Notes Due 2022 106

Boston Scientific Completes Public Offering Of Notes Due 2018 For USD 600 Million 108

Boston Scientific Completes Public Offering Of Notes Due 2023 For USD 450 Million 110

Boston Scientific Acquires Men's Health and Prostate Health Businesses from American Medical Systems for USD1.65 Billion 112

Medifocus Completes Acquisition Of Prolieve Business From Boston Scientific For Up To USD5 Million 114

Boston Scientific to Acquire Augmenix for USD600 Million 115

Boston Scientific to Acquire VENITI 116

Boston Scientific Acquires Claret Medical for up to USD270 Million 117

Boston Scientific to Acquire Remaining 65% Stake in Cryterion Medical 118

Boston Scientific Acquires NxThera 119

Boston Scientific Acquires nVision Medical 120

Boston Scientific Acquires Securus Medical 121

Boston Scientific Acquires EMcision 122

Boston Scientific Announces Investment and Acquisition Option Agreement with Millipede 123

Boston Scientific Acquires Apama Medical 124

Boston Scientific Acquires Symetis for USD435 Million 125

Boston Scientific Acquires 15% Stake in Neovasc for USD7 Million 126

Boston Scientific Acquires EndoChoice for USD214 Million in Tender Offer 127

Boston Scientific Acquires Cosman Medical 129

Boston Scientific Acquires 25% Stake in Frankenman Medical 130

Boston Scientific Acquires Xlumena for USD76 Million 131

Boston Scientific Enters into Option Agreement to Acquire MValve Technologies 132

Boston Scientific Acquires Remaining 72% Stake in IoGyn 133

Vanguard Acquires 6.7% Stake In Boston Scientific 134

Boston Scientific Completes Acquisition of Bard Electrophysiology From C. R. Bard For USD 275 Million 135

Fidelity Acquires 10.5% Stake In Boston Scientific, Medical Device Company 137

EndoChoice Acquires RMS Endoskopie, Endoscopy Device Maker 138

Boston Scientific Completes Acquisition Of Vessix Vascular, Developer Of Catheter-Based Renal Denervation System, For Up to USD425 Million 139

Boston Scientific Completes Acquisition Of BridgePoint Medical, Cardiovascular Device Maker 141

Boston Scientific Completes Acquisition Of Rhythmia Medical, Cardiac Arrhythmia Device Maker, For Up To USD 265 Million 142

Boston Scientific Completes Acquisition Of Cameron Health For Up To USD 1.3 Billion 143

Covidien Completes Acquisition Of superDimension, Pulmonary Device Maker, For USD 300 Million 145

Boston Scientific Corp, Key Competitors 147

Boston Scientific Corp, Key Employees 148

Boston Scientific Corp, Other Locations 150

Boston Scientific Corp, Subsidiaries 151

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Boston Scientific Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 17743
Site License
USD 500 INR 35485
Corporate User License
USD 750 INR 53228

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com